Association of the 894G>T polymorphism of the endothelial constitutive nitric oxide synthase gene with unstable angina

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 4, 2007, Pages 475-483

  Iturry Yamamoto, G R ^a   Moriguchi, E H ^b   Zago, A C ^a   Alho, C S ^c   Zago, A J ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Coronary; Gene; Nitric oxide synthase; Polymorphism; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; THYMINE;

ACUTE CORONARY SYNDROME; AMINO ACID SUBSTITUTION; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BRAZIL; CASE CONTROL STUDY; CHI SQUARE TEST; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART INFARCTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; RISK FACTOR; STABLE ANGINA PECTORIS; UNIVARIATE ANALYSIS; UNSTABLE ANGINA PECTORIS;

ANGINA;

EID: 34247183284     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2006005000072     Document Type: Article

References (34)

1. Worthley SG, Osende JI, Helft G, Badimon JJ, Fuster V. Coronary artery disease: pathogenesis and acute coronary syndromes. Mt Sinai J Med 2001; 68: 167-181.
2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
3. Ignarro LJ, Byms RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61: 866-879.
4. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
5. Azuma H, Ishikawa M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986; 88: 411-415.
6. Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92: 181-187.
7. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 1057-1058.
8. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92: 639-646.
9. Irokawa M, Nishinaga M, Funayama H, Shimada K. The effect of endothelium-derived relaxing factor (EDRF) on anticoagulant heparan sulfate on cultured vascular endothelial cell (EC). Circulation 1994; 90: 1-396.
10. Moilanen E, Vuorinen P, Kankaanranta H, Metsa-Ketela T, Vapaatalo H. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br J Pharmacol 1993; 109: 852-858.
11. Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992; 90: 1116-1121.
12. Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P. Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol 1993; 265: H862-H867.
13. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-17488.
14. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998; 103: 65-69.
15. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T, et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998; 32: 521-526.
16. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, et al. Association of the missense Glu298Asp vadant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998; 31: 1506-1510.
17. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, et al. A common variant of the endothelial nitric oxide synthase (Glu298 → Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999; 100: 1515-1520.
18. Park KW, You KH, Oh S, Chae IH, Kim HS, Oh BH, et al. Association of endothelial constitutive nitric oxide synthase gene polymorphism with acute coronary syndrome in Koreans. Heart 2004; 90: 282-285.
19. Fatini C, Sofi F, Sticchi E, Gensini F, Gori AM, Fedi S, et al. Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J 2004; 147: 516-521.
20. Rios DL, Callegari-Jacques SM, Hutz MH. Endothelial nitric oxide synthase and fractalkine chemokine receptor polymorphisms on angiographically assessed coronary atherosclerosis. Clin Chim Acta 2005; 362: 138-146.
21. Tanus-Santos JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 2001; 11: 719-725.
22. Cases JP, Bautista LE, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 2004; 109: 1359-1365.
23. Braunwald E. Unstable angina. A classification. Circulation 1989; 80: 410-414.
24. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th edn. Boston: Little Brown and Co.; 1994. p 253-256.
25. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990; 82: 1193-1202.
26. Lahiri KD, Numberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
27. Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, Correa RX, et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 2005; 12: 177-182.
28. Naber CK, Baumgart D, Altmann C, Siffert W, Erbel R, Heusch G. eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia. Am J Physiol Heart Circ Physiol 2001; 281: H1908-H1912.
29. Sofowora G, Dishy V, Xie HG, Imamura H, Nishimi Y, Morales CR, et al. In-vivo effects of Glu298Asp, endlothelial nitric oxide synthase polymorphism. Pharmcogenetics 2001; 11: 809-814.
30. Hambrecht R, Erbs S, Adams V, Linke A, Gielen S, Schuler G. Attenuated endothelium-dependent vasodilation in patients with coronary artery disease: Impact of G894T polymorphism of the endothelial nitric oxide synthase. J Am Coll Cardiol 2001; 37 (Suppl A): 286A.
31. Cattaruzza M, Guzik TJ, Slodowski W, Pelvan A, Becker J, Halle M, et al. Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease. Circ Res 2004; 95: 841-847.
32. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A 2000; 97: 2832-2835.
33. Senthil D, Raveendran M, Shen YH, Utama B, Dudley D, Wang J, et al. Genotype-dependent expression of endothelial nitric oxide synthese (eNOS) and its regulatory proteins in cultured endothelial calls. DNA Cell Biol 2005; 24: 218-224.
34. Persu A, Stoenoiu MS, Messiaen T, Davila S, Robino C, El-Khattabi O, et al. Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 2002; 11: 229-241.